Microbial Invasion and Immunosuppression Drives Adenoma Progression in Early Colorectal Cancer Development

The Microbial Gatekeepers of Colorectal Adenomas

Why do some patients develop aggressive colorectal cancer while others, carrying the exact same genetic mutations, see their precancerous polyps simply vanish? Researchers studying Familial Adenomatous Polyposis (FAP)—a condition where inherited mutations in the APC gene make colon polyps almost inevitable—have long sought the "environmental modifier" that decides a polyp's fate.

Current medical understanding views polyps as a predictable, stepwise progression toward malignancy. While we know the genetic blueprint, we struggle to explain the massive variability in disease severity and onset, even among siblings with identical mutations. This leaves a critical gap in preventative medicine. We can identify the risk, but we cannot yet predict which lesions will grow into life-threatening tumors and which will regress.

A new study using a porcine model of FAP suggests the answer may lie in the physical location of microbes. The authors report that bacterial invasion into the tissue is associated with a specialized immune response. This response appears to coincide with a state of immune escape, which may allow the tumor to thrive.

Beyond Simple Dysbiosis

For years, the prevailing theory has focused on "dysbiosis"—a general imbalance in the gut microbiome. The assumption was that if a patient had "bad" bacteria in high concentrations, their risk of cancer increased. However, the authors of this study found that looking at the total abundance of bacteria is an insufficient metric for predicting polyp behavior.

The researchers report that alpha diversity (a measure of how many different species are present and how evenly they are distributed) was comparable across normal tissue, progressing polyps, and regressing polyps [Figure 3A]. Similarly, the broad compositional shifts in the microbiome—what scientists call beta diversity—explained only a tiny fraction of the variance in whether a polyp grew or shrank [Figure 3B].

This suggests that the mere presence of certain microbes isn't the sole deciding factor. Instead, the biological "decision point" may occur when the relationship between the microbe and the host tissue changes from external contact to internal invasion.

A Proposed Model of Progression

To investigate these links, the authors employed a multimodal approach. They combined longitudinal colonoscopies of 82 pigs with high-resolution single-cell RNA sequencing (a method to look at the gene activity of individual cells) and spatial transcriptomics (a technique to map gene activity within intact tissue). They essentially created a high-definition map of the cellular and microbial architecture of the colon.

The authors propose a model where several factors converge during progression:

1. Epithelial Plasticity: As adenomas develop, the epithelial cells (the cells forming the gut lining) may exhibit increased plasticity or progenitor-like programs.
2. Bacterial Infiltration: Unlike regressing polyps, where bacteria remain mostly "lumen-adjacent" (staying on the outer surface of the tissue), progressing polyps show bacterial invasion into adenomatous regions [Figure 6B].
3. Myeloid Reprogramming: The study finds that microbial sensing is linked to the reprogramming of myeloid cells (a category of innate immune cells). Specifically, progressing lesions show an association with immunosuppressive neutrophils (first-responder white blood cells that dampen immune activity) [Figure 5A].
4. T-Cell Exclusion: These environments appear to correlate with the exclusion of cytotoxic T cells (specialized immune cells that kill abnormal cells). This creates a niche that may facilitate lesion expansion [Figure 6D].

The authors suggest this could function as a "feed-forward" circuit. In this model, epithelial changes might permit bacterial entry. The bacteria then associate with suppressive immune cells. This could lead to reduced immune pressure, allowing further epithelial plasticity and tissue disorganization.

Evidence from the Spatial Frontier

The strength of this study lies in its ability to link specific cell behaviors to precise physical locations. Using Xenium spatial transcriptomics, the authors could see which genes were being expressed in which cells and where the bacteria were sitting in relation to them.

The authors demonstrate that in progressing lesions, bacterial transcripts are enriched in both the adenoma cells and the immunosuppressive neutrophils [Figure 6D]. Furthermore, they found a correlation between distance and cell state. Neutrophils located closest to the bacterial signal showed higher scores for immunosuppressive and PD-L1-associated programs [Figure 6G]. In contrast, those further away maintained a more traditional, inflammatory stance.

Regressing polyps showed a different profile. These lesions were characterized by active "immune surveillance," featuring high levels of cytotoxic CD8+ T cells and inflammatory neutrophils [Figure 4C]. The authors also report that regressing polyps exhibit significantly higher rates of apoptosis (programmed cell death)—11.3% compared to 4.3% in progressing polyps [Supplementary Figure 4A]. This higher rate of cell death indicates that regression is an active process of tissue clearance rather than just a pause in growth.

Limitations and Unanswered Questions

While the evidence is compelling, the authors note several gaps in the current data. First, the study establishes a strong association between bacterial invasion and progression, but it does not yet prove causality. It remains unclear if the bacterial invasion is the initiating spark or if the immune shift happens first, making the tissue more vulnerable to invasion.

Second, the spatial profiling was performed at specific time points rather than continuously tracking the same individual lesion. This makes it difficult to capture the exact moment the "switch" from regression to progression occurs. Finally, the microbial analysis used a targeted panel that identifies broad groups of bacteria rather than specific, high-resolution strains. Since different strains of the same species can have vastly different levels of virulence, this granularity is essential for moving toward clinical applications.

The Verdict: A Shift Toward Spatial Biomarkers

The findings represent a significant pivot in how we think about early cancer interception. The study suggests that if we want to predict which polyps are dangerous, we should consider the location of bacteria rather than just their total amount.

Is this ready for the clinic? Not yet. The tools used here are currently far too expensive and complex for routine screening. However, the "bacterial invasion-neutrophil immunosuppression-T-cell exclusion" axis identified by the authors provides a specific target for research. If we can eventually prevent bacterial penetration or disrupt the suppressive signals sent by neutrophils, we might help redirect progressing polyps toward a self-clearing state.

Figures from the paper